URGN · Forms 3, 4, 5
Insider trades at UroGen Pharma Ltd.
1 insider sold $81K of UroGen Pharma Ltd. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for UroGen Pharma Ltd. (URGN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Chris Degnan | Chief Financial Officer | Option exercise | 4,483 | Form 4 | |||
| Chris Degnan | Chief Financial Officer | Sell | 2,202 | $36.69 | $81K | Form 4 | |
| Mark Schoenberg | Chief Medical Officer | Sell | 871 | $42.92 | $37K | Form 4 | |
| Jason Drew Smith | General Counsel | Sell | 1,519 | $42.54 | $65K | Form 4 | |
| Mark Schoenberg | Chief Medical Officer | Option exercise | 1,667 | Form 4 | |||
| Jason Drew Smith | General Counsel | Option exercise | 3,334 | Form 4 | |||
| James A. Robinson Jr. | Director | Option exercise | 2,000 | Form 4 | |||
| Mark Schoenberg | Chief Medical Officer | Sell | 60,677 | $47.05 | $2.9M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.